Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?

Cetin B. , Berk V., Kaplan M. A. , Afsar B., Tufan G., Ozkan M., ...Daha Fazla

CLINICAL GENITOURINARY CANCER, cilt.11, sa.2, ss.141-148, 2013 (SCI İndekslerine Giren Dergi) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Konu: 2
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/j.clgc.2012.09.001
  • Sayfa Sayıları: ss.141-148


In this study, we have undertaken a retrospective review of 100 patient charts to investigate whether neutrophil to lymphocyte ratio (NLR) is associated with progression-free survival (PFS) in metastatic renal cell carcinoma (mRCC) patients treated with second-line vascular endothelial growth factor (VEGF) targeted tyrosine kinase inhibitors (TKIs) after failure of interferon-alpha. We have shown that NLR at diagnosis is an independent predictor of survival in mRCC patients. Investigation of therapies which harness the immune response are warranted in this disease.